Recently, we highlighted two small molecule leaders in the GLP-1R agonism space, orforglipron and danuglipron
BPC-157 complements these mechanisms through its activation of VEGFR2 and eNOS pathways that promote angiogenesis and improve endothelial function, with the peptide's nitric oxide generation supporting vasodilation and reducing thrombotic risk while its growth factor sensitization enhances vascular responses to ischemic conditions
If you have experienced gastroparesis (stomach paralysis), bowel obstruction , or vision loss after taking any GLP-1 medication, you may be eligible to file a lawsuit within MDL 3094
J Clin Endocrinol Metab 109(8):19071947 Halfon M, Phan O, Teta D (2015) Vitamin D: a review on its effects on muscle strength, the risk of fall, and frailty
There are dozens of them, and most have no data behind them